Poonawalla Family's Bombardier Global 6500 lands in Belgrade as Serum Institute CEO visits Serbia

Serbia has courted foreign vaccine investment since the pandemic. In 2021, the government signed an agreement with China's Sinopharm to build a fill-and-finish plant in Belgrade. The Serum Institute has not announced a Serbian partnership, but the company's history of fast-track facility construction — Adar Poonawalla invested $800 million at the peak of COVID-19 to build a new Pune factory, per Forbes — suggests the family is comfortable making large, speculative capital commitments when vaccine demand shifts. A direct flight from Bangalore, India's vaccine-research hub, rather than from Pune headquarters, may indicate the trip originated from a site visit or regulatory meeting.

The family's aviation footprint supports this reading. VT-CDC, one of four Bombardier Global jets operated by the Poonawallas, has flown primarily within India and to Dubai in recent weeks. The long-haul segment to Belgrade — a city not among the family's recurrent destinations of London, Paris, Tokyo, or Singapore — marks a deliberate strategic deviation. Should the aircraft's passengers have been Serum executives, the timing would suggest due diligence on European manufacturing options as the vaccine market normalizes post-pandemic. The Poonawalla family's readiness to travel where the business leads is a quiet signal that the next phase of Serum's growth may not be confined to Pune.